[BostonCard]

Another day, another study further throwing cold water on the possibility that hydroxychloroquine ± azithromycin will work for COVID-19.  This time in animal models:

https://www.nature.com/articles/s41586-0...erence.pdf

Under normal circumstances, this study would have been done first, and then the drug would have been tested in humans.

BC

---

Two-for-one today.

https://www.nejm.org/doi/full/10.1056/NE...4?query=RP

HCQ ± Azithromycin fails to make a difference in patients with mild disease.

Here's the main result



The "ordinal scale" represents categories of severity ranging from 1 (no need for oxygen and no limitations on activity) to 7 (death).  The distribution of the categories is basically the same regardless of treatment.

BC

[BostonCard]

Another day, another study further throwing cold water on the possibility that hydroxychloroquine ± azithromycin will work for COVID-19.  This time in animal models:

https://www.nature.com/articles/s41586-0...erence.pdf

Under normal circumstances, this study would have been done first, and then the drug would have been tested in humans.

BC

---

Two-for-one today.

https://www.nejm.org/doi/full/10.1056/NE...4?query=RP

HCQ ± Azithromycin fails to make a difference in patients with mild disease.

Here's the main result



The "ordinal scale" represents categories of severity ranging from 1 (no need for oxygen and no limitations on activity) to 7 (death).  The distribution of the categories is basically the same regardless of treatment.

BC